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It is well-documented that most human and rodent solid tumours
contain a significant proportion of hypoxic cells (Rockwell et al,
1986; Rockwell and Moulder, 1990). From radiobiology studies,
hypoxia is known to render tumour cells resistant to ionizing irra-
diation (Bristow and Hill, 1998). Methods to detect hypoxia might
allow identification of patients with radioresistant tumours who
would benefit from selective, hypoxia-targeting treatment strate-
gies. Presently, the determination of oxygen concentration with
polarographic electrodes is the only method of measuring hypoxia
that has been extensively studied in patients. Decreased tumour
oxygenation, as measured with polarographic electrodes, has been
reported to be a predictor of poor local response following radio-
therapy in cervix cancer (Höckel et al, 1993; Fyles et al, 1998;
Sundfør et al, 1998; Knocke et al, 1999; Lyng et al, 2000) head and
neck cancer (Gatenby et al, 1988; Nordsmark et al, 1996; Brizel 
et al, 1997) and soft tissue sarcoma (Brizel et al, 1996). Recently,
clinical data have emerged suggesting that hypoxia adversely
affects locoregional control of cervical cancer, irrespective
whether the initial treatment modality is radiotherapy or surgery
(Höckel et al, 1996). For soft tissue sarcoma, poorer oxygenation
has also been linked to increased likelihood of developing distant
metastasis (Brizel et al, 1996). Thus, in addition to radioresistance,
hypoxia may be implicated in local tumour aggressiveness and
distant progression. 
Our lab has previously demonstrated in a murine model that
metastasis formation by rodent tumour cells can be increased by
exposure to hypoxia (Young et al, 1988). When murine fibrosar-
coma cells were exposed to hypoxia in vitro they acquired a tran-
sient, enhanced ability to form experimental metastases. We
hypothesized that a hypoxic environment induces genomic insta-
bility, possibly through gene amplification. Other investigators
have reported hypoxia-mediated increased mutation frequencies in
tumours (Reynolds et al, 1996) and selection of cells deficient in
genes of normal regulatory pathways (Graeber et al, 1996; Kim et
al, 1997). In addition, it is well recognized that hypoxic stimuli can
alter gene expression by up-regulating specific transcription
factors and, at a post-transcriptional level, by increasing mes-
senger RNA stability (Ikeda et al, 1995; Dachs and Stratford,
1996; Iyer et al, 1998; Sutherland, 1998; Dachs and Tozer, 2000;
Semenza, 2000). Intensive investigations are ongoing to elucidate
the complex mechanisms underlying these epigenetic/genetic
interactions. 
In the previous study by Young et al (1988) metastasis forma-
tion was examined with rodent tumour cells after exposure to
hypoxia in vitro and intravenous injection of tumour cells back
into the animal. The availability of polarographic electrodes
allowing direct measurements of tumour oxygenation stimulated
us to re-address the question of whether hypoxia affects distant
metastasis formation using a spontaneous metastasis model. In the
current study we performed direct measurements of oxygenation
in individual primary tumours in vivo and investigated their ability
to form metastases in the lungs. 
MATERIALS AND METHODS 
Mice and tumour cell lines 
Experiments were carried out with 2 murine tumour cell lines,
KHT-C fibrosarcoma and SCC-VII squamous cell carcinoma.
Their origin has been described previously (Bristow et al, 1990).
Both cell lines were maintained in the present lab by alternate in
vitro and in vivo passage. In vitro passage was done in plastic
flasks, growing cells as monolayers in a-minimal essential
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medium (Gibco BRL, Burlington, Ontario) supplemented with
10% fetal bovine serum (FBS, Wisent, Quebec). Cells were
removed from the monolayer while in exponential growth with
0.05% trypsin for 5 minutes at 37˚C. Tumour cells were used for
experiments between their 2–4th passage in vitro and established
in syngeneic 8–12-week-old C3H/HeJ male mice (The Jackson
Laboratory, Bar Harbor, Maine). Approximately 2.5 ´ 105 cells,
suspended in 30–50 ml growth medium were injected into the left
gastrocnemius muscle. Tumour growth was followed by external
measurement of the diameter of the tumour-bearing leg. All
animals were selected for oxygen measurements when this diam-
eter reached a size of 9 (± 0.5) mm (corresponding tumour weight
0.3–0.4 g). This generally occurred 8 days after injection. Animals
were housed at the Ontario Cancer Institute animal colony and had
access to food and water ad libitum. Experiments were performed
according to the regulations provided by the Canadian Council on
Animal Care. 
Tumour oxygenation measurements 
Direct oxygen measurements were made in individual tumours
using a polarographic oxygen electrode (Eppendorf pO2
Histograph, Kimoc 6650, Hamburg, Germany) as reported previ-
ously (Kavanagh et al, 1996, 1999). Calibrations were performed
according to the manufacturer’s recommendations. All pO2
measurements were made approximately 15 minutes after induc-
tion of anaesthesia with intraperitoneally injected Ketalean
(ketamine hydrochloride, 50 mg kg–1) (M.T.C. Pharmaceuticals,
Cambridge, Ontario) and Rompun (xylazine, 5 mg kg–1) (Bayvet
Division, Chemagro Limited, Etobicoke, Ontario). Anaesthetized
mice were positioned on a heating pad. Core temperature was
monitored and kept at 37 ± 2˚C. In each tumour, 8–12 measure-
ments were made along each of 6 parallel tracks resulting in a total
of 48–72 pO2 values per tumour. The pO2 data for each tumour
were corrected for tumour temperature, which was measured at
one point similar in position to an Eppendorf track, using a 25
gauge needle thermocouple probe (Model #2300A, Fluke
Electronics Canada Inc, Mississauga, Ontario). Oxygen measure-
ments were performed in a total of 103 KHT-C tumours and 67
SCC-VII tumours at a tumour weight of 0.3–0.4 g. This was done
in several experiments. In each experiment a number of mice were
randomly allocated for cervical dislocation immediately after pO2
measurements. Mice that were not sacrificed following oxygen
measurements were monitored during recovery and kept under
close surveillance until the tumour bearing leg reached a diameter
of 15 (± 0.5) mm (corresponding tumour weight 1.8–1.9 g). 
Metastasis assessment 
As lungs are the primary site of metastasis formation from leg
tumours for both KHT-C and SCC-VII cells, the development of
lung metastases was assessed. 
After oxygen measurements at a tumour weight of 0.3–0.4 g, a
total of 86 tumours (40 KHT-C and 46 SCC-VII) randomly selected
from the group KHT-C and SCC-VII tumours were grown until the
tumour-bearing leg had reached a tumour weight of 1.6–1.9 g. At
this tumour size, the animals were killed by cervical dislocation,
their lungs were removed, briefly washed with distilled water,
cleaned of extraneous tissue, fixed in Bouin’s solution overnight
(BDH Inc, Toronto, Ontario) and stored in buffered formalin 10%
(BDH Inc, Toronto, Ontario) until they were counted. 
A total of 84 animals (63 bearing KHT-C and 21 SCC-VII
tumours) was sacrificed immediately after oxygen measurements
at a tumour weight of 0.3–0.4 g. Lungs were similarly fixed in
Bouin’s solution followed by storage in formalin. In both experi-
ments, the 5 lung lobes of each animal were coded and examined. 
Macroscopically visible metastases were counted using a
dissecting microscope. In the absence of macroscopic lung metas-
tases, lung lobes were embedded in paraffin. 4 histological
sections at least 20 mm apart were cut through each lobe and
stained with haematoxylin and eosin. The rationale for cutting 4
sections is based on work by Thrall et al (1997), who showed in
tumour biopsies that, for quantification of hypoxic marker
labelling, 4 randomly selected sections provide an accurate est-
imate of the truly labelled area. The presence of microscopic
metastasis was evaluated at a 10´ magnification using a trans-
mitted light microscope. Lungs were classified as positive if at
least one section revealed a micrometastasis. Likewise, lungs were
scored as negative in the absence of any micrometastases. 
Data evaluation 
Hypoxic fractions, defined as the percentage of pO2 values lower
than 5 mm Hg, and median pO2 values were computed from the
histogram, calculated from the pooled needle track readings of
each individual tumour, using the pO2 pool software package
(Eppendorf). A Mann–Whitney test was applied to test differences
in oxygenation between the KHT-C and SCC-VII tumours (Figure
1A, B) and differences in number of macroscopic lung metastases
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Figure 1 Percentage of pO2 values lower than 5 mmHg as a function of
median pO2 for (A) 103 KHT-C and (B) 67 SCC-VII tumours, measured at a
tumour weight of 0.3–0.4 g. Each point represents the measurements from
an individual tumour. The dashed lines indicate the overall median value 
of each parameter for the group of KHT-C tumours (A) and SCC-VII 
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between hypoxic and non-hypoxic KHT-C tumours. A Spearman
rank correlation coefficient was calculated for evaluation of the
correlation between macroscopic lung metastases and oxygen
status in the primary KHT-C tumours (Figure 2). Pearson’s Chi-
squared test with Yates correction was applied to compare fre-
quencies in the contingency tables. The level of significance was
defined as P < 0.05 (two-sided). 
RESULTS 
Tumour oxygenation measurements 
The results of the oxygen measurements in mouse tumours of
0.3–0.4 g are plotted in Figure 1A for 103 individual KHT-C
tumours and in Figure 1B for 67 individual SCC-VII tumours. In
both figures, the percentage of pO2 values lower than 5 mmHg is
plotted as a function of the median pO2. The dashed lines indicate
the median value for each parameter. The hypoxic proportion,
represented by the percentage of pO2 values lower than 5 mmHg
ranges from 25.3% to 100% (median 68%) and from 28.6% to
100% (median 72.7%) in KHT-C and SCC-VII respectively. There
is no statistically significant difference in median hypoxic propor-
tion between the two tumour cell lines (P = 0.52). For both tumour
cell lines, a considerable inter-tumour heterogeneity in oxygena-
tion is observed. The spectra of inter-tumour heterogeneity
however are similar for both tumour cell types. 
Metastasis assessment 
Macroscopic lung metastasis at tumour weight 1.6–1.9 g 
For KHT-C, the number of macroscopically visible lung metas-
tases as counted using a dissecting microscope is plotted versus the
fraction of pO2 values lower than 5 mmHg at a tumour weight of
0.3–0.4 g in Figure 2A. This graph is updated from previously
reported preliminary results (De Jaeger et al, 1998). Although
there seems to be a trend suggesting increasing incidence of lung
metastases with increasing hypoxic fraction, there is only a weak,
non-significant correlation (rs = 0.19, P = 0.25). Also, analysis of
these data by dividing the tumours at the median value for the
hypoxic fraction demonstrated that the number of lung metastases
is not significantly different for primary tumours with an oxygena-
tion level above or below the median (median number of lung
metastases 18.5 versus 29, P = 0.21). Macroscopic lung metastases
were not detected in any of the 46 SCC-VII tumours analysed. 
Microscopic lung metastasis at tumour weight 0.3–0.4 g 
Because all but 2 of the animals with KHT-C tumours examined at
a primary tumour weight of 1.6–1.9 g had metastases and many
had a large number of metastases, we also examined the extent of
metastases at an earlier stage of tumour growth. 
Table 1 summarizes the results of the evaluation of microscopic
lung metastasis for KHT-C when the tumour-bearing animals were
assessed for hypoxic fraction and then killed at a tumour weight of
0.3–0.4 g. Each individual animal was classified in this 2 ´ 2 table
according to whether the hypoxic fraction in the tumour (at tumour
weight 0.3–0.4 g) was above/equal to or below the overall median
percentage of values lower than 5 mmHg, and whether it was posi-
tive or negative for lung metastases, based on the evaluation of 4
independent histological sections. In 45 of 63 lungs, at least one
microscopic metastasis was present. In 32 of these 45 mice with
lung metastases, measurement of oxygen level in the primary
revealed a hypoxic proportion above or equal to 68%, representing
the overall median percentage of values < 5 mmHg. Thus, hypoxic
tumours seem to metastasize at an earlier stage of growth more
frequently as compared to better-oxygenated tumours. Likewise, a
higher proportion of negative lungs was observed in mice with
relatively better-oxygenated tumours. These proportions are
significantly different (6c2 = 6.178, P = 0.0143). The number of
micrometastases observed in the lungs from each mouse is plotted
versus the fraction of pO2 values lower than 5 mmHg in Figure 2B
for comparison with the data for macroscopic metastases. Analysis
of these results demonstrated a significant correlation between the
hypoxic proportion and the number of microscopic lung metas-
tases (rs = 0.50, P < 0.01). The number of lung metastases is also
significantly different for primary tumours with a hypoxic propor-
tion above or below the median of 68% (median number of lung
metastases 3.5 versus 1.0, P < 0.01). 
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Figure 2 Number of lung metastases in each of 40 (A) or 63 (B) mice
bearing KHT-C tumours as a function of the percentage of pO2 values 
<5 mmHg measured at tumour weight 0.3–0.4 g. The mice were killed for
assessment of macroscopic lung metastases when the tumours reached a
weight of 1.6–1.9 g (A) and for assessment of microscopic lung metastases
at tumour weight of 0.3–0.4 g (B) 
Table 1 Classification of 63 animals with KHT-C tumours according to
% pO2 values <5 mmHg ³ or < the overall median of 68%, and positive or
negative for microscopic lung metastasis. Oxygen measurements and lung
metastases were both evaluated at tumour weight 0.3–0.4 g 
% pO2 values Lung metastasis Total 
<5 mmHg Positive Negative 
³68 32 6 38 
<68 13 12 25 
Total 45 18 63 Hypoxia and metastasis 1283
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A similar series of studies was undertaken with SCC-VII
tumours. Table 2a shows that the incidence of spontaneous meta-
stasis at 0.3–0.4 g is very low in this tumour cell line with
detectable metastasis development in only 3/21 animals. The
numbers are very small and do not suggest any correlation
between oxygenation status and metastasis formation in SCC-VII.
Following the observation of low metastatic incidence at tumour
weight 0.3–0.4 g in SCC-VII, we also examined the lungs from
mice killed at a primary tumour weight 1.6–1.9 g for microscopic
metastasis. These results are summarized in Table 2b. Even at a
larger tumour size, only 6/46 tumours demonstrated detectable
lung metastasis. Again, there was no correlation with the oxygena-
tion status of the primary tumour at 0.3–0.4 g. 
DISCUSSION 
In the present study the effect of hypoxia in vivo on the formation
of distant metastases was examined in 2 murine tumour cell lines.
We utilized the Eppendorf Histograph to measure oxygen concen-
trations because it is currently the only clinically applicable tech-
nique whose strong predictive value in terms of radioresistance,
tumour progression and metastasis has been extensively docu-
mented in patients (Gatenby et al, 1988; Höckel et al, 1993; Brizel
et al, 1996; Höckel et al, 1996; Nordsmark et al, 1996; Brizel et al,
1997; Fyles et al, 1998; Sundfør et al, 1998, Knocke et al, 1999,
Lyng et al, 2000). 
Data on the relationship between direct measurements of
oxygenation in rodent tumours and radiation curability have been
reported (Nordsmark et al, 1995) but the relationship to metastasis
formation has, to our knowledge, not been previously addressed in
a murine model. 
We observed substantial intra-tumour heterogeneity in oxygena-
tion of KHT-C and SCC-VII tumours. Both tumour types,
measured at tumour weight 0.3–0.4 g show variation within an
almost identical range (Figure 1A, B). This range is in agreement
with our preliminary data (De Jaeger et al, 1998) and with data
obtained in our lab in a different group of KHT-C tumours
(Kavanagh et al, 1999). We have previously shown in KHT
tumours that consecutive measurements of pO2 in the same tumour
give similar results and that there is a correlation in individual
KHT tumours between measurements of pO2 made when the
tumours were 0.3–0.4 g and when they were 1.0–1.1 g in size (De
Jaeger et al, 1998). We and others have postulated that variation in
pO2 values, measured in individual tumours from the same cell
line, at the same size and transplanted in identical hosts, are likely
to be a consequence of differences associated with local tumour
growth and stochastic development of vasculature rather than
intrinsic genetic differences (Rockwell and Moulder, 1990; De
Jaeger et al, 1998). Similar heterogeneity in oxygenation, but over
a wider range has been reported in human tumours (Gatenby et al,
1988; Höckel et al, 1993, 1996; Brizel et al, 1995, 1996, 1997;
Nordsmark et al, 1996; Fyles et al, 1998; Sundfør et al, 1998). 
The SCC-VII and KHT-C tumours were found to be quite
dissimilar in terms of metastasis formation, despite the compa-
rable oxygenation status in vivo of both tumour types. For SCC-
VII, the overall incidence of lung metastases was very low. There
was no difference whether the lungs were examined at a tumour
weight 0.3–0.4 g or 1.6–1.9 g, either for macroscopic or micro-
scopic metastases. Also, there was no correlation with oxygena-
tion status in the primary tumour. However, when pooling the
results of Tables 2a and 2b a slight trend for a relationship between
metastasis formation and oxygenation status was observed (7/9
mice with lung metastasis had hypoxic primary tumours) but the
correlation was not significant. 
In the KHT-C model metastases were much more frequent. At a
tumour weight 1.6–1.9 g, macroscopic metastases were present in
the majority of the lungs with only 2/40 mice not showing macro-
scopically visible pulmonary metastases. As depicted in Figure 2A
only a weak non-significant correlation was observed between
oxygenation of the primary tumour at tumour weight 0.3–0.4 g and
the number of lung metastases observed at weight 1.6–1.9 g. We
hypothesized that a possible relationship could be obscured by the
presence of massive lung metastases when the primary tumours
reach a weight of 1.6–1.9 g and by the fact that the tumours
become increasingly hypoxic as their weight increases above 0.3 g
(De Jaeger et al, 1998). In a previous study (Hill et al, 1986)
we showed that KHT-C fibrosarcoma starts seeding metastases
into the lungs at a tumour weight of 0.25 g (corresponding leg
diameter = 7.5–8 mm). 
Consequently, we decided to examine whether hypoxia in the
primary tumour correlates with metastasis formation in the lungs
at an earlier time point (tumour weight 0.3–0.4 g) in the process of
seeding. Table 1 and Figure 2b represent the results for 63 KHT-C
tumours and illustrate that hypoxic KHT-C tumours, defined as
tumours with a percentage of pO2 readings < 5 mmHg above or
equal to the median percentage of 68%, gave rise to significantly
more positive lungs and micrometastases as compared to better-
oxygenated tumours. This result, suggesting that hypoxic KHT
tumours are more likely to be metastatic is consistent with the clin-
ical data obtained in head and neck cancer, cervix cancer and soft
tissue sarcoma (Brizel et al, 1996; Höckel et al, 1996; Rofstad
et al, 2000; Walenta et al, 2000). Preliminary analysis from the
clinical study of oxygenation of cervix cancer being conducted at
the Princess Margaret Hospital (Fyles et al, 1998) has indicated
increased nodal metastases in the patients with more hypoxic
tumours (Pitson et al, 2001). 
There is growing evidence from laboratory studies supporting
the clinical observations that the significance of hypoxia in cancer
Table 2a Classification of 21 animals with SCC- VII tumours according to
% pO2 values <5 mmHg ³ or < the overall median of 72.7%, and positive or
negative score for microscopic lung metastasis. Oxygen measurements and
lung metastases were both evaluated at tumour weight 0.3–0.4 g 
% pO2 values Lung metastasis Total 
<5 mmHg Positive Negative 
³72.7 2 8 10 
<72.7 1 10 11 
Total 3 18 21 
Table 2b Classification of 46 animals with SCC- VII tumours according to
% pO2 values <5 mmHg ³ or < the overall median of 72.7%, and positive or
negative score for microscopic lung metastasis. Oxygen measurements were
performed at tumour weight 0.3–0.4 g. Lung metastases were evaluated at
tumour weight 1.6–1.9 g 
% pO2 values Lung metastasis Total 
<5 mmHg Positive Negative 
³72.7 5 19 24 
<72.7 1 21 22 
Total 6 40 46 1284 K De Jaeger et al 
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may extend far beyond the traditional scope of radioresistance.
Young et al (1988) have shown that exposure of murine KHT
fibrosarcoma cells to hypoxia in vitro results in a transient
enhancement of their ability to form lung metastases. They
suggested that gene amplification, associated with DNA over-
replication, was responsible for the enhanced metastatic potential.
Further studies of the expression of a number of metastasis-related
genes following hypoxic exposure did not identify a gene whose
altered expression correlated with the increased metastatic
potential of the cells, although vascular endothelial growth factor
(VEGF) was up-regulated (Jang and Hill, 1997). In similar experi-
ments with human melanoma cells, other groups found that expo-
sure to hypoxia promotes metastasis formation (Hartmann et al,
1999; Rofstad and Danielsen, 1999). They demonstrated a correla-
tive up-regulation of the expression of VEGF (Hartmann et al,
1999; Rofstad and Danielsen, 1999) and angiogenin (Hartmann
et al, 1999), both potent angiogenic factors. The effect of the
tumour microenvironment on metastasis has been reviewed
recently (Rofstad, 2000). 
Reynolds et al (1996) studied the impact of fluctuating hypoxia
on the frequency of mutations arising in a shuttle vector carried in
a tumorigenic mouse cell line. They detected a 3–4-fold increase in
mutation frequency under severe hypoxic conditions. Their results
indicate that the environmental conditions within solid tumours
can be mutagenic and suggest that hypoxia mediates tumour
progression by induction of genetic instability. Similar findings
have been reported by Sandhu et al (2000), who examined HPRT
mutations in MN-11 tumor cells. Graeber and colleagues (Graeber
et al, 1996; Kim et al, 1997) found that hypoxia can mediate the
selection of cells deficient in genes of normal regulatory pathways.
This group demonstrated that hypoxia provides a selective pres-
sure for cells mutant in the p53 tumour-suppressor gene resulting
in decreased apoptotic potential and establishment of a more
malignant phenotype. Furthermore, it has been well documented
that hypoxic stimuli can alter the expression of a myriad of genes,
transcription factors, growth factors, cytokines, metabolic and
invasive enzymes (Stoler et al, 1992; Dachs and Stratford, 1996;
Jang and Hill, 1997; Sutherland, 1998; Graham et al, 1999; Dachs
and Tozer, 2000; Semenza, 2000). Despite tremendous progress in
understanding fundamental mechanisms of hypoxia-induced
genetic, metabolic and chemical alterations in cells, it still remains
unclear how and whether these alterations act in concert. Also,
oxygenation is not a binary physiological condition and the contri-
bution of transient and chronic changes on these interactions
remains to be determined. The results in this paper establish the
KHT fibrosarcoma as a model system for such studies. 
Moreover, it should be pointed out that hypoxia is not the only
tumour microenvironmental condition affecting tumour progres-
sion. Other factors, such as pH and low glucose may play a role
(Schlappack et al, 1991). Also, hypoxia per se does not necessarily
imply metastatic ability. This is clearly illustrated in the SCC-VII
model where, despite severe hypoxia in the primary tumours, cells
fail to metastasize. Limitations related to the model, such as
heterotopic implantation could have contributed to the metastatic
inefficiency of SCC-VII cells. It is well known from the work of
Fidler (1990) that orthotopic models give rise to higher metastatic
rates. Therefore, the i.m. transplanted KHT model is likely to be a
more relevant representative of natural tumour behaviour than i.m.
transplanted SCC-VII tumours. 
In summary, this is the first report investigating the relationship
between direct measurements of tumour oxygenation in vivo and
metastatic behaviour of rodent tumours. In the KHT-C model,
early metastatic ability was found to be enhanced in hypoxic
tumours. The present results are consistent with previous clinical
and laboratory findings indicating that hypoxia may contribute to
malignant progression. The availability of this model allows in
vivo testing of hypoxia-directed strategies leading to potentially
effective treatment. However, as demonstrated in the SCC-VII
model, there are factors other than hypoxia which affect the
metastatic ability of tumour cells. 
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